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Edited by Sandro SonninoAbstract Phytol is a naturally occurring precursor of phytanic
acid. The last step in the conversion of phytol to phytanoyl-CoA
is the reduction of phytenoyl-CoA mediated by an, as yet,
unidentiﬁed enzyme. A candidate for this reaction is a previously
described peroxisomal trans-2-enoyl-CoA reductase (TER). To
investigate this, human TER was expressed in E. coli as an
MBP-fusion protein. The puriﬁed recombinant protein was
shown to have high reductase activity towards trans-phytenoyl-
CoA, but not towards the peroxisomal b-oxidation intermediates
C24:1-CoA and pristenoyl-CoA. In conclusion, our results show
that human TER is responsible for the reduction of phytenoyl-
CoA to phytanoyl-CoA in peroxisomes.
 2006 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Phytanic acid1. Introduction
Peroxisomes are organelles, present in virtually each eukary-
otic cell, that carry out a large variety of metabolic functions.
One of these functions is the a-oxidation of 3-methyl-
branched-chain fatty acids, like phytanic acid. In this process
the carbon chain of phytanic acid is shortened by one carbon
atom, leading to a 2-methyl-branched-chain fatty acid, i.e.,
pristanic acid [1,2]. In contrast to 3-methyl-branched-chain
fatty acids, 2-methyl-branched-chain fatty acids can be de-
graded by b-oxidation, which is another metabolic process that
takes place in the peroxisome. The ﬁrst step in peroxisomal
b-oxidation of pristanic acid is catalyzed by branched-chain
acyl-CoA oxidase, which introduces a double bond at the
2,3-position, to form a trans-2-enoyl-CoA. After a dehydration
and dehydrogenation reaction both catalyzed by the D-bifunc-
tional protein localized in the peroxisome, the resulting
3-ketoacyl-CoA is thiolytically cleaved by one of the peroxi-
somal thiolases, resulting in a shortened fatty acyl-CoA. After
three cycles of peroxisomal b-oxidation, the shortened acyl-
CoA, i.e., 4,8-dimethylnonanoyl-CoA, is not a substrate forAbbreviations: CPT1, carnitine palmitoyl transferase 1; IPTG, isopro-
pyl-1-thio-b-D-galactopyranoside; MBP, maltose-binding protein;
TER, trans-2-enoyl-CoA reductase
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doi:10.1016/j.febslet.2006.03.011the peroxisomal acyl-CoA oxidases anymore. For further
breakdown, the chain-shortened product is transported to
the mitochondrion [3], where it is totally degraded to acetyl-
CoA and propionyl-CoA units [4]. Besides breakdown of
pristanic acid, peroxisomal b-oxidation is also involved in
the degradation of very long-chain fatty acids, long-chain
dicarboxylic acids and bile acid intermediates [4].
Another metabolic process that recently has been shown to
occur, at least partly, in the peroxisome is the degradation of
phytol. Phytol is a branched-chain fatty alcohol (3,7,11,15-
tetramethylhexadec-2-en-1-ol) abundantly found in nature as
part of the chlorophyll molecule. The release of phytol from
chlorophyll occurs eﬀectively in the digestive system of rumi-
nant animals only, presumably by bacteria present in the gut
[5]. As a result, a relatively high amount of free phytol is pres-
ent in dairy products [6]. In mammals, free phytol is readily
absorbed in the small intestine and metabolized mainly in
the liver (manuscript in preparation). The product of phytol
degradation is phytanic acid, which accumulates in a number
of metabolic disorders. First, phytol is converted into phytenic
acid at the endoplasmic reticulum by the subsequent action of
an alcohol dehydrogenase and an aldehyde dehydrogenase.
Subsequently, phytenic acid is activated to its CoA ester by
an acyl-CoA synthetase. Phytenoyl-CoA synthetase activity
has been detected in both microsomes and peroxisomes [7].
Finally, phytenoyl-CoA is reduced to phytanoyl-CoA by a
reductase. Subcellular localization studies of rat liver homoge-
nates have shown that phytenoyl-CoA reductase activity was
present in both mitochondria and peroxisomes. Since
phytanoyl-CoA is further broken down via the peroxisomal
a-oxidation, it is tempting to speculate that in vivo the last
steps of phytol degradation take place in the peroxisome.
Interestingly, the degradation of phytol is stereospeciﬁc
towards the breakdown of trans-phytol, also named (E)-phytol
(manuscript in preparation).
In a previous study, the cloning of a peroxisomal trans-2-en-
oyl-CoA reductase (TER), an enzyme with an unknown func-
tion but proposed to play a role in fatty acid chain elongation,
was described [8]. This reductase has aﬃnity for trans-2-enoyl-
CoA esters with chain lengths up to 16 carbon atoms and ap-
pears to be ubiquitously expressed with high levels present in
liver and kidney [8].
In our study, we investigated whether this enzyme catalyzes
the last step in the conversion of phytol to phytanic acid, i.e.,
the reduction of trans-phytenoyl-CoA into phytanoyl-CoA.
The results described in this paper show that trans-phyte-
noyl-CoA is readily reduced by TER to yield phytanoyl-
CoA. Furthermore, TER also showed activity towardsblished by Elsevier B.V. All rights reserved.
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carbon atoms. Interestingly, TER hardly reacted with priste-
noyl-CoA and trans-2-tetracosenoyl-CoA (C24:1-CoA), two
trans-2-enoyl-CoAs that are formed as intermediates during
peroxisomal b-oxidation.2. Materials and methods
2.1. Materials
E. coli strain INVa was purchased from Invitrogen (Carlsbad,
CA). Yeast extract and tryptone were obtained from Difco Labora-
tories Inc. (Detroit, MI). The pGEM-T vector and T4-DNA ligase
and ligation buﬀer were purchased from Promega (Madison, WI).
The pMAL-C2X vector and amylose resin columns were from New
England Biolabs (Beverly, MA). Completemini tablets containing a
cocktail of protease inhibitors were purchased from Roche (Basel,
Switzerland). trans-2-Butenoyl-CoA (C4:1-CoA) was obtained from
Sigma–Aldrich (St. Louis, MO). trans-2-Hexenoyl-CoA (C6:1-CoA),
trans-2-octenoyl-CoA (C8:1-CoA), trans-2-decenoyl-CoA (C10:1-CoA),
trans-2-dodecenoyl-CoA (C12:1-CoA), trans-2-tetradecenoyl-CoA
(C14:1-CoA), trans-2-hexadecenoyl-CoA (C16:1-CoA), C24:1-CoA
were enzymatically synthesized from the corresponding saturated
CoA esters using acyl-CoA oxidase from Arthrobacter (Sigma–Al-
drich). A mixture of cis- and trans-phytenic acid was synthesized as de-
scribed previously [9]. A mixture of cis- and trans-phytenoyl-CoA
isomers was chemically synthesized from this mixture as described be-
fore [10]. All other chemicals were of analytical grade.
2.2. Cloning, expression and puriﬁcation of human TER cDNA in E. coli
The complete open reading frame (ORF) of human TER was
ampliﬁed from control human liver cDNA by PCR using the follow-
ing primerset: a BamHI-tagged forward primer 5 0-tataggatccAT
GGCCTCCTGGGCTAAGGG-30 and a SalI-tagged reverse primer
5 0-tatagtcgacAGGACACCTTGTTTCCTCAG-3 0 (restriction sites
are underlined). The PCR product was ﬁrst inserted into pGEM-T
and sequenced to exclude PCR-introduced mutations. Subsequently,
the ORF was cloned into the bacterial expression vector pMAL-C2X
(New England Biolabs), using the BamHI and SalI sites downstream
of the isopropyl-1-thio-b-D-galactopyranoside (IPTG) inducible
promoter in frame with the ATG, in order to express TER as a fusion
protein with maltose-binding protein (MBP). E. coli strain INVa was
transformed with pMAL-TER. Transformed cells were grown at
37 C in 10 ml LB-medium supplemented with 0.2% (w/v) glucose
and 150 lg/ml ampicillin to an OD600 of approximately 0.6 and IPTG
was added to a ﬁnal concentration of 1 mM to induce expression of the
fusion protein. After 4 h at 37C, cells were collected by centrifugation
for 5 min at 1000 · g. The pellet was dissolved in phosphate-buﬀered
saline solution with 0.1% (v/v) Triton X-100 and protease inhibitor
cocktail. Cell lysates were prepared by sonication for 3 periods of
20 s at 8–9 W in an ice water bath followed by centrifugation at
12000 · g for 15 min at 4 C. The supernatant was used for puriﬁca-
tion of the MBP-fusion protein using amylose resin as described by
the manufacturer (New England BioLabs). The puriﬁed protein was
stored at 20 C in PBS containing 50% (v/v) glycerol.Fig. 1. SDS–polyacrylamide gel analysis of puriﬁed recombinant
human trans-2-enoyl-CoA reductase (TER). Human TER was
expressed in E. coli as an MBP fusion protein and subsequently
puriﬁed using amylose resin. Indicated amounts of the puriﬁed protein
were applied on an SDS–polyacrylamide gel. The gel was stained with
Coomassie brilliant blue G-250.2.3. SDS–polyacrylamide gel electrophoresis
0.5, 1 and 2 lg of the puriﬁed recombinant MBP-TER were applied
on a 10% (w/v) SDS–polyacrylamide gel [11]. The gel was stained with
Coomassie brilliant blue G-250 according to the method described in
[12].
2.4. 2-Enoyl-CoA reductase activity measurements
Enoyl-CoA reductase activity with diﬀerent trans-2-enoyl-CoA
esters as substrates, including phytenoyl-CoA, pristenoyl-CoA, C4:1-
CoA, C6:1-CoA, C8:1-CoA, C10:1-CoA, C12:1-CoA, C14:1-CoA,
C16:1-CoA and C24:1-CoA, was determined essentially as described
previously [7]. Brieﬂy, the reaction mixture contained 50 mM bis-
Tris–propane, pH 7.2, 1 mM NADPH, 50 lM of the 2-enoyl-CoA es-
ter and 1 lg of the puriﬁed MBP-TER in a ﬁnal volume of 100 ll.
Reactions were started by addition of substrate and incubated at
37 C for 15 min. Reactions with phytenoyl-CoA, pristenoyl-CoAand C24:1-CoA as a substrate were terminated by the addition of
100 ll acetonitrile and placed on ice. Reactions with all other sub-
strates were terminated by the addition of 2 M HCl to a ﬁnal concen-
tration of 0.18 M, followed by neutralization to a pH of 6 by
addition of 0.6 M MES plus 2 M KOH. Acetonitrile was added to a
ﬁnal concentration of 20%. All samples were spun for 10 min at
10000 · g at 4 C. Supernatants were analyzed using high performance
liquid chromatography and CoA esters were quantiﬁed using UV-
detection. To this end, 50 ll samples were injected on a C18 reversed-
phase column (Supelcosil LC-18-DB, 250 mm · 4.6 mm internal
diameter, particle size 5 lm, Supelco). Elution of the CoA esters was
performed using either a linear gradient of methanol in 50 mM potas-
sium phosphate buﬀer (pH 5.3) for short-chain substrates (C4:1-CoA
and C6:1-CoA), or a linear gradient of acetonitrile in 16.9 mM sodium
phosphate buﬀer (pH 6.9) for all other substrates. Resolution between
substrate and product using a methanol gradient was achieved using a
linear gradient of 26–50% methanol over 20 min for C4:1-CoA incuba-
tions and of 14–26% methanol over 30 min for C6:1-CoA incubations.
Resolution between CoA esters using an acetonitrile gradient was
achieved using a linear gradient of 16–34% acetonitrile over 30 min
for C8:1-CoA incubations, of 40–54% acetonitrile over 23 min for
incubations with substrates ranging in chain length from 10 to 16 car-
bon atoms, and of 49–51% in 24 min for incubations with C24:1-CoA
and phytenoyl-CoA.3. Results and discussion
3.1. Expression and puriﬁcation of recombinant MBP-TER
The full-length cDNA of human TER [8] was expressed as a
fusion protein with MBP in E. coli. After induction, the cells
expressing MBP-TER showed high reductase activity towards
phytenoyl-CoA, whereas no phytenoyl-CoA reductase activity
was observed in cells transformed with the empty pMAL vec-
tor (data not shown). The recombinant fusion protein, MBP-
TER, bound tightly to an amylose resin column and could
be eluted with maltose. The purity of the isolated fusion pro-
tein was established by SDS–PAGE (Fig. 1). The expected
molecular weight of the fusion protein is 75 kDa, which corre-
sponds well with the apparent molecular weight of the protein
observed on SDS–PAGE. The phytenoyl-CoA reductase activ-
ity of the puriﬁed enzyme was stable for at least a month, when
stored at 20 C in PBS containing 50% (v/v) glycerol.
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recombinant MBP-TER
Optimal reaction conditions were determined using a mix-
ture of cis- and trans-phytenoyl-CoA as substrate. The
reduction of phytenoyl-CoA by recombinant MBP-TER
was stereospeciﬁc, since only the trans-isomer was reduced
to phytanoyl-CoA. The reaction was dependent on NADPH
as cofactor with a Km of 106 lM (Fig. 2A). Maximum activ-
ity was observed in incubation mixtures with a pH between0
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Fig. 2. Characterization of human recombinant MBP-TER. (A) Speciﬁc activ
CoA and various concentrations of NADPH. From Michaelis–Menten plot
optimum. (C) Dependence on protein concentration. (D) Time course. (E) I
trans-phytenoyl-CoA. From Michaelis–Menten plot (inset) a Km of 18 lM w7 and 7.5 (Fig. 2B). Based on these ﬁndings a pH of 7.2 was
used in all other experiments. Phytanoyl-CoA production
was linear with protein up to 20 lg/ml (Fig. 2C) and linear
over time up to at least 30 min (Fig. 2D). In Fig. 2E, the
dependence of the reductase reaction on the substrate
trans-phytenoyl-CoA was studied. Calculation of the Km
and Vmax resulted in 18 lM and 172 nmol/mg/min,
respectively.
In a previous study, the reduction of phytenoyl-CoA in rat
liver homogenate was investigated [7]. The pH optimum for0
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dent on NADPH, although the Km was much lower. This dif-
ference could be due to the MBP-moiety of the puriﬁed protein
that was used in this study. Another explanation for the diﬀer-
ence is the fact that phytenoyl-CoA reductase activity was ob-
served in both mitochondria and peroxisome enriched
fractions of rat liver density gradient centrifugation experi-
ments. Since TER is a peroxisomal enzyme, the mitochondrial
activity probably originates from another reductase with reac-
tivity towards phytenoyl-CoA that has other enzymatic prop-
erties.
The reverse reaction, from phytanoyl-CoA to phytenoyl-
CoA, did not take place in incubations with recombinant
MBP-TER, NADP+ and an NADP-regenerating system.
4.1. Characterization of the reductase activity of recombinant
MBP-TER towards other substrates
Several straight-chain trans-2-enoyl-CoAs were tested as
substrate for the recombinant MBP-TER and reductase activ-
ity was measured with substrates having a carbon chain rang-
ing in length from 4 to 16 carbon atoms (Fig. 3). Highest
activity was observed for C8:1-CoA with a Km and Vmax of
17 lM and 651 nmol/mg/min, respectively. Although the Vmax
is higher for the reduction of C8:1-CoA than of phytenoyl-
CoA, the Km values for the reduction of C8:1-CoA and phyte-
noyl-CoA are quite similar.
Intermediates of peroxisomal b-oxidation, C24:1-CoA and
pristenoyl-CoA (2,6,10,14-tetramethylpentadec-2-enoyl-CoA),
were also tested as substrates for recombinant MBP-TER.
Interestingly, the speciﬁc activity for C24:1-CoA was only
1% of that of phytenoyl-CoA, whereas no reduction of the
pristenoyl-CoA could be detected at all. This suggests that
only CoA esters with a methyl-group at the 3-position as in
phytenoyl-CoA, and not at the 2-position as in pristenoyl-
CoA, are substrates for TER.200 400 600
C4:1-CoA
C6:1-CoA
C8:1-CoA
C10:1-CoA
C12:1-CoA
C14:1-CoA
C16:1-CoA
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Fig. 3. Speciﬁc activity (SA) of recombinant MBP-TER measured
with diﬀerent 2-enoyl-CoA esters. Enzyme activity measurements with
diﬀerent substrates were performed in a reaction mixture with a ﬁnal
concentration of 10 lg/ml recombinant MBP-TER, 1 mM NADPH,
50 mM bis-Tris–propane pH 7.2 and 50 lM of the substrate. Reactions
were carried out for 15 min at 37 C.TERhas been shown to possess a peroxisomal targeting signal
1, that directs the protein to the peroxisome. Of the trans-2-en-
oyl-CoA esters that were tested as substrate for the recombinant
MBP-TER, C24:1-CoA, pristenoyl-CoA and phytenoyl-CoA
are formed in the peroxisome and not the mitochondrion,
whereas medium-chain 2-enoyl-CoA esters are formed in both
mitochondria and peroxisomes and short-chain 2-enoyl-CoA
esters are only formed by b-oxidation in the mitochondria.
Interestingly, the intermediates of peroxisomal b-oxidation,
C24:1-CoA and pristenoyl-CoA, are not readily reduced by
recombinant MBP-TER, leaving phytenoyl-CoA as the only
true peroxisomal substrate with high aﬃnity for TER.
Although the data presented suggest that TER has a function
in phytol metabolism in vivo, further investigations are re-
quired. First, development of an antiserum against TER is
needed to establish its exclusive location in the peroxisome.
Also, immunoprecipitation experiments could be performed
to investigate the percentage of phytenoyl-CoA reductase activ-
ity in liver homogenates that is attributable to TER. Finally, to
elucidate the role of mitochondria in the reduction of phyte-
noyl-CoA in vivo, studies on phytenoyl-CoA import into the
mitochondrion have to be done. For the import of phytenoyl-
CoA into the mitochondrion, phytenoyl-CoA has to be con-
verted to phytenoyl-carnitine by carnitine palmitoyl transferase
1 (CPT1). This carnitine ester then can be imported into the
mitochondrion via the carnitine-acylcarnitine translocase and
reconverted into the corresponding CoA ester again in the
mitochondrion by carnitine palmitoyl transferase 2. Prelimin-
ary studies revealed that CPT1 activity towards phytenoyl-
CoA is less than 5% of its activity towards palmitoyl-CoA (data
not shown). This suggests that phytenoyl-CoA is not readily
imported into the mitochondrion for further degradation.
In conclusion, our results suggest that TER has a function in
phytol metabolism, where it is responsible for the reduction of
phytenoyl-CoA to phytanoyl-CoA. Since relatively low aﬃni-
ties towards peroxisomal b-oxidation intermediates were ob-
served, its putative role in peroxisomal chain elongation as
suggested by Das et al. [8] remains controversial.Acknowledgements: The authors thank J. Koster for technical assis-
tance. This work was supported by Grant 901-03-097 from the Neth-
erlands Organization for Scientiﬁc Research (NWO, The Hague, The
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